Volume Number
29
Issue Number
7
Date
Publication
Neurology Reviews
Cover image
Priority Articles
The aducanumab revolution
New AHA/ASA guideline on secondary stroke prevention
FDA expands rimegepant indication to include migraine prevention
FDA clears next-generation DBS system for movement disorders
Almost half of patients with migraine are reluctant to seek care
Many comatose TBI patients recover consciousness during rehab
Fremanezumab fails posttraumatic headache test
Sustained long-term benefit of gene therapy for SMA
Young adults with epilepsy face higher mental illness risks
A large proportion of migraine patients are not offered preventive treatment
Large vessel stroke linked to AstraZeneca COVID vaccine
Migraine linked to more COVID-19 infections, symptoms but less health care utilization
Deep brain stimulation is effective over the long haul
Ubrogepant effective for acute migraine even with preventive monoclonal antibody therapy
Psychosis, depression tied to neurodegeneration in Parkinson’s
e-TNS device passes at-home test
A high-stakes numbers game
Moving more, sitting less vital for migraine patients
AHA: Physical activity best first-line for high BP, cholesterol
Cannabinoids promising for improving appetite, behavior in dementia
Neurologists brace and prepare for long-COVID fallout
LAAOS III: Surgical LAA closure cuts AFib stroke risk by one third
Cover image